SCHEMBL2237566

SCHEMBL2237566

Cc1ccc2c(c1-c1ccc3ccccc3c1)C=C(Br)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.40
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
HSD17B10 Q99714 3/20 0.33
CYP1A2 P05177 3/20 0.33
KDM4E B2RXH2 3/20 0.33
TP53 P04637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
KLF5 Q13887 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
DHFR P00374 1/20 0.33
GSTP1 P09211 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236464 0.82 ALDH1A1 (0.34) ALDH1A1HSD17B10CYP3A4TDP1GRIA1
SCHEMBL2235659 0.82 AKT2 (0.31) KDM4EKMT2AMAPTHPGDTDP1
SCHEMBL2234221 0.78 MEN1 (0.31) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL2235097 0.77 MAPT (0.37) SMN1; SMN2KDM4EMEN1KMT2AMAPT
SCHEMBL2234742 0.76 IKBKB (0.34) IKBKBALDH1A1SMN1; SMN2HSD17B10CYP1A2
SCHEMBL2236190 0.76 CYP1A1 (0.34) ALDH1A1SMN1; SMN2CYP1A2TP53MEN1
SCHEMBL2235094 0.76 KIF11 (0.37) IKBKB
SCHEMBL2235465 0.75
SCHEMBL2235892 0.75 DHFR (0.40) ALDH1A1SMN1; SMN2CYP1A2KDM4ETSHR
SCHEMBL2236088 0.74 IKBKB (0.41) IKBKBALDH1A1SMN1; SMN2HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2360163-B1 METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN JAPAN POLYPROPYLENE CORP (JP) 2014-06-25 EP disclosed
US-8461365-B2 Metallocene complex and polymerization method of olefin JAPAN POLYPROPYLENE CORPORATION (JP) 2013-06-11 US disclosed
CN-102245620-A Metallocene complex and method for polymerizing olefin JAPAN POLYPROPYLENE CORP 2011-11-16 CN disclosed
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN JAPAN POLYPROPYLENE CORPORATION (JP) 2011-09-22 US disclosed
EP-2360163-A1 METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN Japan Polypropylene Corporation (JP) 2011-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN ALOX12, ALOX15, ALOX15B IKBKB 3916/4885ALDH1A1 477/4885SMN1; SMN2 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.